Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review-Reference-Cited by-同舟云学术

Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review

Published:2021-03 Issue:3 Volume:39 Page:180-190
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Laukhtina Ekaterina,Pradere Benjamin,Mori Keiichiro,Schuettfort Victor M.,Quhal Fahad,Mostafaei Hadi,Sari Motlangh Reza,Katayama Satoshi,Grossmann Nico C.,Moschini Marco,Enikeev Dmitry,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference58 articles.

1. Cancer statistics, 2019;Siegel;CA. Cancer J. Clin.,2019

2. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the EAU Annual Congress Amsterdam;Witjes;EAU Guidelines Office,2020

3. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†[Formula presented]: Under the Auspices of the EAU-ESMO Guidelines Committees;Witjes;Eur. Urol.,,2020

4. Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer;Rosenblatt;Eur. Urol.,2012

5. Perioperative systemic therapy for bladder cancer;Eulitt;Current Opinion in Urology,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma?;Molecular Diagnosis & Therapy;2023-10-24

2. Diagnostic Strategies for Urologic Cancer Using Expression Analysis of Various Oncogenic Surveillance Molecules—From Non-Coding Small RNAs to Cancer-Specific Proteins;Applied Sciences;2022-07-22

3. Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder;Current Opinion in Urology;2022-07-15

4. Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape;Société Internationale d’Urologie Journal;2022-07-15

5. Molecular Oncology of Bladder Cancer from Inception to Modern Perspective;Cancers;2022-05-24